178 related articles for article (PubMed ID: 1904040)
21. [Sex hormone changes in male epileptics on long-term anti-convulsant therapy (author's transl)].
Hoffmann H; Kahlert T
Nervenarzt; 1981 Dec; 52(12):715-7. PubMed ID: 6798479
[No Abstract] [Full Text] [Related]
22. Factors affecting reproductive hormones in HIV-infected, substance-using middle-aged women.
Santoro N; Lo Y; Moskaleva G; Arnsten JH; Floris-Moore M; Howard AA; Adel G; Zeitlian G; Schoenbaum EE
Menopause; 2007; 14(5):859-65. PubMed ID: 17415019
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of different modalities of LHRH agonist (buserelin) administration on the inhibition of the pituitary-ovarian axis for the treatment of endometriosis.
Lemay A; Maheux R; Jean C; Faure N
Prog Clin Biol Res; 1986; 225():157-73. PubMed ID: 3097663
[No Abstract] [Full Text] [Related]
24. Endocrine parameters in acne vulgaris.
Schmidt JB; Lindmaier A; Spona J
Endocrinol Exp; 1990 Dec; 24(4):457-64. PubMed ID: 2151388
[TBL] [Abstract][Full Text] [Related]
25. [The effect of a single electroconvulsive shock on pituitary-thyroid-adrenal-gonadal axis function in men with severe depression--preliminary report].
Motta E; Ostrowska Z; Kazibutowska Z; Paluch M; Płonka J; Gołba A
Psychiatr Pol; 2005; 39(3):469-79. PubMed ID: 16149757
[TBL] [Abstract][Full Text] [Related]
26. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period.
Missmer SA; Spiegelman D; Bertone-Johnson ER; Barbieri RL; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):972-8. PubMed ID: 16702379
[TBL] [Abstract][Full Text] [Related]
27. Administration of nasal Buserelin as compared with subcutaneous Buserelin implant for endometriosis.
Donnez J; Nisolle-Pochet M; Clerckx-Braun F; Sandow J; Casanas-Roux F
Fertil Steril; 1989 Jul; 52(1):27-30. PubMed ID: 2501110
[TBL] [Abstract][Full Text] [Related]
28. Relationship between gonadotrophins, inhibin and sex steroid secretion during the periovulatory period and the luteal phase in the blue fox (Alopex lagopus).
Mondain-Monval M; Farstad W; Smith AJ; Roger M; Lahlou N
J Reprod Fertil Suppl; 1993; 47():47-56. PubMed ID: 8229964
[TBL] [Abstract][Full Text] [Related]
29. Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis.
Lemay A; Maheux R; Faure N; Jean C; Fazekas AT
Fertil Steril; 1984 Jun; 41(6):863-71. PubMed ID: 6427019
[TBL] [Abstract][Full Text] [Related]
30. Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study.
Dmowski WP; Radwanska E; Binor Z; Tummon I; Pepping P
Fertil Steril; 1989 Mar; 51(3):395-400. PubMed ID: 2493400
[TBL] [Abstract][Full Text] [Related]
31. [Inhibitory effect of prolactin secretion by luteinizing hormone releasing hormone agonist (buserelin)].
Inoue T; Matsuoka R; Mori H; Kigawa T
Nihon Naibunpi Gakkai Zasshi; 1986 Jun; 62(6):745-53. PubMed ID: 3093292
[TBL] [Abstract][Full Text] [Related]
32. Changes in circulating hormone levels after ovarian wedge resection in patients with polycystic ovary syndrome.
Szilágyi A; Rossmanith W; Csermely T; Csaba I
Arch Gynecol Obstet; 1990; 248(1):31-5. PubMed ID: 2124095
[TBL] [Abstract][Full Text] [Related]
33. The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women.
Mathur RS; Landgrebe SC; Moody LO; Semmens JP; Williamson HO
Maturitas; 1985 Jul; 7(2):129-33. PubMed ID: 3929023
[TBL] [Abstract][Full Text] [Related]
34. Studies on GnRH agonist suppression of estrogen production in patients with endometriosis.
Ohtsuka S; Terakawa N; Shimizu I; Sakata M; Mizutani T; Miyake A; Tanizawa O; Aono T
Endocrinol Jpn; 1989 Aug; 36(4):611-9. PubMed ID: 2510993
[TBL] [Abstract][Full Text] [Related]
35. Treatment of estrogen-dependent gynecological disorders with the gonadotropin releasing hormone agonist buserelin.
Biberoglu K; Gursoy R; Yildiz A
Gynecol Endocrinol; 1991 Jun; 5(2):109-22. PubMed ID: 1833953
[TBL] [Abstract][Full Text] [Related]
36. Serum concentration and urinary excretion of the luteinizing hormone-releasing hormone agonist buserelin in patients with endometriosis.
Kiesel L; Sandow J; Bertges K; Jerabek-Sandow G; Trabant H; Runnebaum B
J Clin Endocrinol Metab; 1989 Jun; 68(6):1167-73. PubMed ID: 2498387
[TBL] [Abstract][Full Text] [Related]
37. GnRH-agonist therapy in women with the polycystic ovarian syndrome: effects on ovarian volume and on gonadotropin and sex steroid levels.
Dale PO; Tanbo T; Haug E; Abyholm T
Gynecol Endocrinol; 1989 Dec; 3(4):309-15. PubMed ID: 2516706
[TBL] [Abstract][Full Text] [Related]
38. Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results.
Venturini PL; Fasce V; Costantini S; Anserini P; Cucuccio S; de Cecco L
Fertil Steril; 1990 Dec; 54(6):1021-7. PubMed ID: 2147154
[TBL] [Abstract][Full Text] [Related]
39. A randomized, prospective comparison of endocrine changes induced with intranasal leuprolide or danazol for treatment of endometriosis.
Tummon IS; Pepping ME; Binor Z; Radwanska E; Dmowski WP
Fertil Steril; 1989 Mar; 51(3):390-4. PubMed ID: 2522062
[TBL] [Abstract][Full Text] [Related]
40. Effect of spironolactone on sex hormones in man.
Stripp B; Taylor AA; Bartter FC; Gillette JR; Loriaux DL; Easley R; Menard RH
J Clin Endocrinol Metab; 1975 Oct; 41(4):777-81. PubMed ID: 1176584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
